NHS England updates CDF List

NHS England has upded the Cancer Drugs Fund List on its website. We have updated our website to correspond.

NHS England updates CDF List

NHS England has updated the Cancer Drugs Fund List. The latest version (v1.370) was uploaded to the NHS England Website on Tuesday 29, July 2025.

The following changes have been introduced:

Durvalumab in combination with tremelimumab (DUR6)

For first-line systemic treatment of adult patients with locally advanced or metastatic and/or unresectable hepatocellular carcinoma where the following criteria have been met

Recommended for routine commissioning, receiving CDF interim funding

Atezolizumab in combination with bevacizumab (ATE8)

For the first-line systemic treatment of adult patients with locally advanced or metastatic and/or unresectable hepatocellular carcinoma where the following criteria have been met

Treatment criteria (#2, 5 and 11) updated